# Clinical and Applied Research Strategies for the Prevention and Control of Fungal Diseases

Source: https://welltoldgrants.com/grants/rfa-ck-23-001-clinical-and-applied-research-strategies-for-the-prevention/  
Official notice: https://www.grants.gov/search-results-detail/345842

> Centers for Disease Control and Prevention - ERA offered grants of up to $1.5 million (at least $1.0 million) to nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. It expected to make one award worth $7.5 million in total. Applications closed on April 28, 2023.

| Field | Value |
|---|---|
| Opportunity number | RFA-CK-23-001 |
| Agency | Centers for Disease Control and Prevention - ERA |
| Status | Forecast |
| Deadline | April 28, 2023 |
| Award ceiling | $1.5 million |
| Award floor | $1.0 million |
| Expected awards | 1 |
| Total funding | $7.5 million |
| Cost sharing | not required |
| Assistance Listings | 93.084 |

## Who can apply

- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities/Indian housing authorities
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- For profit organizations other than small businesses
- Small businesses
- Others (see text field entitled "Additional Information on Eligibility" for clarification)

An organization that has a Memorandum of Understanding (MOU) with the Mycoses Study Group (MSG) and functions to be its fiduciary entity is eligible to apply. Proof of such an existing relationship is a required document in the application.

## What the grant funds

The purpose of this notice of funding opportunity (NOFO) is to support clinical and applied research that will ultimately help reduce illness and death due to fungal diseases around the world caused by both known and emerging pathogens.

## Questions people ask

### Is RFA-CK-23-001 still open?

No. It closed on April 28, 2023. A newer notice is open: PA-27-100, due dates in the notice, expires April 5, 2027.

### Who can apply for Clinical and Applied Research Strategies for the Prevention and Control of Fungal Diseases?

Centers for Disease Control and Prevention - ERA accepted applications from nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. The notice adds further conditions, so read its eligibility section.

### What is the deadline for Clinical and Applied Research Strategies for the Prevention and Control of Fungal Diseases?

Closed April 28, 2023. Applications are no longer accepted; the program's newer notices are on this page when there are any.

### How much funding is available?

Awards of up to $1.5 million each. About $7.5 million in total for one award.

### Who has won Prevention of Disease, Disability, and Death by Infectious Diseases   grants before?

The largest recipients over five fiscal years were Puerto Rico Science, Technology, and Research Trust, Massachusetts Department of Public Health, Emory University. The program made 128 awards worth $241 million in that time.